American National Insurance’s Alexion Pharmaceuticals ALXN Stock Holding History

American National Insurance’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-28,900	Closed	-$4.42M	–	364
2021 Q1	$4.42M	Sell	28,900 -150	-0.5%	-$23.2K	0.18%	163
2020 Q4	$4.54M	Hold	29,050	–	–	0.19%	144
2020 Q3	$3.32M	Hold	29,050	–	–	0.16%	152
2020 Q2	$3.26M	Hold	29,050	–	–	0.17%	146
2020 Q1	$2.61M	Hold	29,050	–	–	0.17%	145
2019 Q4	$3.14M	Hold	29,050	–	–	0.16%	151
2019 Q3	$2.85M	Hold	29,050	–	–	0.15%	163
2019 Q2	$3.81M	Hold	29,050	–	–	0.2%	136
2019 Q1	$3.93M	Hold	29,050	–	–	0.21%	137
2018 Q4	$2.83M	Hold	29,050	–	–	0.17%	152
2018 Q3	$4.04M	Hold	29,050	–	–	0.2%	141
2018 Q2	$3.61M	Hold	29,050	–	–	0.18%	160
2018 Q1	$3.24M	Hold	29,050	–	–	0.16%	164
2017 Q4	$3.47M	Buy	+29,050	New	+$3.54M	0.17%	162

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

American National Insurance's ALXN Position: Q2 2021 in Review

American National Insurance sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 28,900 shares — an estimated $4.42M sold.

American National Insurance first reported a position in ALXN in Q4 2017 and held it in 14 quarters. The position peaked at $4.54M in Q4 2020. 708 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

American National Insurance reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
American National Insurance sold 28,900 Alexion Pharmaceuticals shares in Q2 2021, an estimated $4.42M.
American National Insurance first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 14 quarters.
American National Insurance's Alexion Pharmaceuticals position peaked at $4.54M in Q4 2020.
708 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on American National Insurance's 13F filing for Q2 2021, filed 10 Aug 2021.